BRKR
Undervalued by 54.4% based on the discounted cash flow analysis.
Market cap | $6.33 Billion |
---|---|
Enterprise Value | $8.73 Billion |
Dividend Yield | $0.2 (0.478468899521531%) |
Earnings per Share | $0.76 |
Beta | 1.16 |
Outstanding Shares | 151,600,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 79.61 |
---|---|
PEG | -120.96 |
Price to Sales | 1.87 |
Price to Book Ratio | 3.43 |
Enterprise Value to Revenue | 2.53 |
Enterprise Value to EBIT | 54.12 |
Enterprise Value to Net Income | 109 |
Total Debt to Enterprise | 0.3 |
Debt to Equity | 1.42 |
No data
No data
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...